Lieke H. J. Simkens

Suggest Changes
Learn More
Background Hand-foot syndrome (HFS) is a common side-effect of capecitabine. S-1 is an oral fluoropyrimidine with comparable efficacy to capecitabine in gastrointestinal cancers but associated with a(More)
Currently, the use of bevacizumab in combination with fluoropyrimidine-containing chemotherapy is the standard first-line treatment for patients with advanced colorectal cancer (ACC). However, only a(More)
BACKGROUND The frequency of capecitabine-related cardiotoxicity has been reported to be low but includes serious adverse events. We conducted a retrospective analysis of the incidence and severity of(More)